Mastectomy Patients’ Knowledge Level about Breast Lymphedema Prevention
DOI:
https://doi.org/10.21070/ijhsm.v2i1.159Keywords:
Breast Cancer, Lymphedema, Prevention, Patient Education, MastectomyAbstract
Background: Breast cancer-related lymphedema (BCRL) is a prevalent and debilitating complication following breast cancer treatment, significantly impairing patients’ quality of life. Specific Background: Despite its impact, prevention strategies are often underemphasized in post-mastectomy care. Knowledge Gap: Limited patient education and awareness about BCRL preventive measures hinder early intervention. Aim: This study aimed to assess the knowledge level of mastectomized patients regarding BCRL prevention. Methods: A descriptive study was conducted using non-probability sampling at Baqubah Teaching Hospital's Oncology Ward. Data were collected through a structured instrument comprising socio-demographic, clinical, and knowledge-related items and analyzed using descriptive and inferential statistics. Results: Findings revealed a mean knowledge score of 2.26, indicating that the majority of participants had a moderate understanding of BCRL preventive measures. Novelty: This study highlights a critical need for proactive educational interventions targeted at mastectomized patients, emphasizing prevention rather than post-onset management. Implications: Integrating continuous patient education into nursing practice is essential to enhance knowledge and reduce the incidence of BCRL, ultimately improving long-term patient outcomes.
Highlights:
-
Early education on lymphedema prevention is crucial post-mastectomy.
-
Most patients demonstrated only moderate knowledge levels.
-
Nurses play a key role in ongoing patient education.
Keywords: Breast Cancer, Lymphedema, Prevention, Patient Education, Mastectomy
References
[1] Soran, W. Wu, A. Dirican, R. Johnson, O. Andacoglu and J. Wilson, "Estimating the Probability of Lymphedema After Breast Cancer Surgery," Am. J. Clin. Oncol., vol. 34, no. 5, pp. 506–510, Oct. 2021.
[2] J. C. Acebedo, "Minimizing Breast Cancer-Related Lymphoedema," Pract. Nurs., vol. 26, no. 2, pp. 79–83, Jan. 2025.
[3] Shah, D. Arthur, J. Riutta, P. Whitworth and F. A. Vicini, "Breast-Cancer Related Lymphedema: A Review of Procedure-Specific Incidence Rates, Clinical Assessment Aids, Treatment Paradigms and Risk Reduction," Breast J., vol. 18, no. 4, pp. 357–361, Jul.–Aug. 2022.
[4] N. E. Mahdi and R. A. Ali, "Effect of Pre-Discharge Guidelines on Women's Knowledge and Self-Care Practices Regarding Arm Lymphedema Prevention Post-Mastectomy," J. Am. Sci., vol. 8, no. 12, pp. 1003–1017, Dec. 2022.
[5] L. Hoskins and D. Daugherty, "Disease Management: Establishing Standards of Care for Lymphedema Treatment," Lymph Link, vol. 15, no. 4, pp. 5–26, 2023.
[6] L. L. Rourke, K. Hunt and J. N. Cormier, "Breast Cancer and Lymphedema: A Current Overview for the Healthcare Provider," Women’s Health, vol. 6, no. 3, pp. 399–406, 2020.
[7] Poage, M. Singer, J. Armer, M. Poundall and J. Shellabarger, "Demystifying Lymphedema: Development of the Lymphedema Putting Evidence Into Practice," Clin. J. Oncol. Nurs., vol. 12, no. 6, pp. 951–964, Dec. 2020.
[8] M. K. McClure, R. J. McClure, R. Day and A. M. Brufsky, "Randomized Controlled Trial of the Breast Cancer Recovery Program for Women With Breast Cancer-Related Lymphoedema," Am. J. Occup. Ther., vol. 64, no. 1, pp. 59–72, 2020.
[9] C. Ozaslan and B. Kuru, "Lymphedema After Treatment of Breast Cancer," Am. J. Surg., vol. 187, no. 1, pp. 69–72, 2024.
[10] B. Smoot, J. Wong, B. Cooper, L. Wanek, K. Topp, N. Byl and M. Dodd, "Upper Extremity Impairments in Women With or Without Lymphoedema Following Breast Cancer Treatment," J. Cancer Surviv., vol. 4, no. 2, pp. 167–178, 2020.
[11] J. Ferlay, I. Soerjomataram, R. Dikshit, S. Eser, C. Mathers, M. Rebelo, D. M. Parkin, D. Forman and F. Bray, "Cancer Incidence and Mortality Worldwide: Sources, Methods and Major Patterns in GLOBOCAN 2012," Int. J. Cancer, vol. 136, no. 5, pp. 359–386, 2025.
[12] N. Alwan, "Breast Cancer: Demographic Characteristics and Clinico-Pathological Presentation of Patients in Iraq," East. Mediterr. Health J., vol. 16, no. 11, pp. 1073–1078, 2020.
[13] K. Larouche and M. F. Witty, "Treatment of Cancer-Related Secondary Lymphedema," INESSS Le Savoir Prend Forme, vol. 7, no. 3, pp. 14–17, Apr. 2021.
[14] S. F. Shaitelman, K. D. Cromwell, J. C. Rasmussen, N. L. Stout, J. M. Armer, B. B. Lasinski and J. N. Cormier, "Recent Progress in the Treatment and Prevention of Cancer-Related Lymphedema," CA Cancer J. Clin., vol. 65, no. 1, pp. 55–81, 2022.
[15] Jang, M. Kim, S. Oh and J. Kim, "The Influence of Arm Swelling Duration on Shoulder Pathology in Breast Cancer Patients With Lymphedema," PLoS One, vol. 10, no. 11, pp. 1–7, 2025.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Abbas Hamid Kamil, Ayat Ibrahim Mrahib , Ammar Abdulkhaleq Ali

This work is licensed under a Creative Commons Attribution 4.0 International License.